Genenta Science S.p.A.
GNTA
$2.30
$0.010.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -8.91% | -8.42% | -5.80% | -11.87% | -17.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.26% | -13.94% | -16.74% | -23.09% | -28.70% |
| Operating Income | 8.26% | 13.94% | 16.74% | 23.09% | 28.70% |
| Income Before Tax | 2.00% | 15.20% | 23.43% | 26.78% | 29.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.00% | 15.20% | 23.43% | 26.78% | 29.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.00% | 15.20% | 23.43% | 26.78% | 29.84% |
| EBIT | 8.26% | 13.94% | 16.74% | 23.09% | 28.70% |
| EBITDA | 8.22% | 13.97% | 16.81% | 23.23% | 28.89% |
| EPS Basic | 3.40% | 15.94% | 23.68% | 26.94% | 29.90% |
| Normalized Basic EPS | 3.36% | 15.89% | 23.66% | 26.96% | 29.93% |
| EPS Diluted | 3.40% | 15.94% | 23.68% | 26.94% | 29.90% |
| Normalized Diluted EPS | 3.36% | 15.89% | 23.66% | 26.96% | 29.93% |
| Average Basic Shares Outstanding | 1.60% | 0.96% | 0.31% | 0.21% | 0.11% |
| Average Diluted Shares Outstanding | 1.60% | 0.96% | 0.31% | 0.21% | 0.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |